Wereport the successful managementof cerebral vasculitis in a 46-year-old womanwith longstanding rheumatoid arthritis with low-dose methotrexate. She suddenly developed dysarthria and left hemiparesis. Magnetic resonance imaging disclosed ischemia of the right pons, and angiography demonstrated cerebral vasculitis of vertebro-basilar arteries. The vasculitis was refractory with high-dose steroid therapy, which had only transient clinical benefit, and evolution to the pontine infarction followed. Her clinical status showed marked improvement in association with recovery of the vascular abnormalities after the initiation of the methotrexate therapy. (Internal Medicine 33: 615-620, 1994) 
Introduction
While the central nervous system (CNS) is usually spared in rheumatoid arthritis (RA), several patients have been reported to suffer from CNSinvolvement. These manifestations result from various causes associated with the diversity of the disease process of RA (1) . Cursory review of the literature revealed very rare cases of cerebral vasculitis in RA, usually with a fatal outcome (2) (3) (4) (5) (6) (7) (8) (9) . Here, we describe a patient with RAwho developed cerebral infarction due to vasculitis of vertebrobasilar arteries, and showed striking clinical and angiographic recovery by low-dose methotrexate (MTX)therapy.
Case Report
A 46-year-old woman, with definite RAsince the age of 30, was admitted to the hospital because of dysarthria and left hemiparesis of sudden onset. It had been well controlled with prednisolone (5 mg/day), piroxicam (10 mg/day), and sodium aurothiomalate (25 mg/week). Laboratory data in the outpatient clinic revealed a rheumatoid factor (RF) of 70.5-176 (normal <20) IU/ml, and C-reactive protein (CRP) of 0.3-0.7 mg/dl.
Other serological, biochemical, hematological data and urinalyses were within the normal ranges. On admission, her consciousness was mildly disturbed, and she had complaints of severe throbbing pain over the occiput, Lumbar cerebrospinal fluid (CSF) showed the initial and the final pressure of 220 and 160 mmH20,respectively, and 32 white cells/jal, all of which were lymphocytes. CSFglucose and protein were 5 1 and 62 mg/dl, respectively. Gram and acid-fast stains, routine culture, and fungal culture of the CSFwere subsequently negative. Cryptococcal antigen on latex beads was negative. Complement fixation tests for herpes simplex and zoster were within the normal ranges. Soluble immune complexes (<1.0 ug/ml), IgG (4.0 mg/dl), and myelin basic Figure 1 summarizes the clinical course of the patient.
In the subsequent several days, her general condition was stable. She became alert and did not complain ofa headache. On the tenth hospital day, she became hypotensive and left paresthesia occurred in addition to the exacerbation of left hemiparesis. The second MRIscan revealed an area of slightly decreased signal intensity on TrWI at the right side of the pons. On T2-WIthe signal of the lesion was intensified in relation to that of the intact part. Progressive ischemia of the right part of the pons was suspected. The basilar artery was severely stenotic with flow-enhancement due to slow blood flow on TrWI ( hospital day, her vital signs recovered and dopamine was withdrawn, but the neurological deficits remained unchanged. She then underwent a second angiographic examination. The four-vessel study disclosed progressive multiple segments of narrowing and dilatation involving bilateral carotid arteries as well as vertebro-basilar arteries, and markedly impaired cerebral blood perfusion. Maximuminvolvement was noticed again in the distal end of the right vertebral artery (Fig. 3 ). Methyl-prednisolone was tapered and withdrawn; it was replaced with prednisolone (50 mg/day), and MTX(5 mg/week). Aortography, celiac and renal angiographies performed on the 34th hospital day in search of systemic involvement of rheumatoid vasculitis, revealed no abnormalities. Prednisolone was tapered to 10 mg/2 days. Her vital signs remained stable, and dysarthria and left hemiparesis gradually improved. Left paresthesia also improved leaving residual numbness of the lateral side of the left forearm and foot. MRIscan performed on the 76th hospital day demonstrated decreased signal intensity at the right side of the pons on Tj-WI, which was very high on T2-WI, suggesting completion of infarction. However, the diameter of the basilar artery was enlarged without flow-enhancement (Fig. 2) . On the 86th hospital day, angiography showed marked improvement of cerebral vasculitis. Then, she was discharged to outpatient care with low-dose MTX(5 mg/week) 
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Dextran 40^^^" Sodium Ozagrel å ^^å å å å hm Do pam ine å å å å å å å å Pr e dni s o l o ne H^^-w^m^^^^^^M etho tr e x at e "å "å ~-^---^^-^i^-. and prednisolone (10 mg/2 days). Ten months after the episode, cerebral angiography performed for confirmation disclosed an almost normal appearance of vertebro-basilar arteries, and recovery of the cerebral blood flow (Fig. 3) . CRP, RF and ESR after the episode remained relatively stable (<0.3-0.5 mg/dl, <20-34 IU/ml and 22-28 mm/h, respectively) wthout other serious abnormalities of laboratory data, and regular checkups with MRIand magnetic resonance angiography have disclosed no significant changes. She has been enjoying daily life as a housewife without the need for analgesics for morethan a year and a half.
Discussion
In RA, the CNSmay be affected by compressive dural nodules, rheumatoid pachymeningitis, vertebral subluxation, and hyperviscosity syndrome (1 commonlyconsists of dermal manifestations , cerebral vasculitis rarely gives rise to neurological complications in RA(2-9, 1 1). Similar to the majority of previously reported cases, the present case had a long-standing history of RA, which required steroid therapy. The diagnosis of rheumatoid cerebral vasculitis was made by cerebral angiography. MRIscan qualitatively disclosed the injured area. Other causes of cerebral vasuclitis has been suggested to be related to steroid therapy (3, 5) .
Moreover, the published observations of cases of rheumatoid cerebral vasculitis, in whomRAhad been treated with steroids, revealed a poor prognosis (2) (3) (4) (5) (6) (7) (8) (9) . Steroid therapy over a long period of time might have affected cerebral vasculitis in the present case.
Although MTXis a highly effective second-line agent and is widely used for RA, its use in rheumatoid vasculitis is controversial. Some reports have discussed the effectiveness of MTXfor cutaneous vasculitis (12, 13) , and aggravation of systemic rheumatoid vasculitis after discontinuation of MTX (14) . Other reports have described accelerated nodulosis and vasculitis during MTXtherapy forrheumatoid arthritis ( 1 5 , 1 6).
In the present patient, on follow-up angiograms cerebral vasculitis was clearly shown to be improved with low-dose MTXtherapy. Low-dose MTXtherapy may be a treatment of choice in rheumatoid cerebral vasculitis, if it is intractable with steroids.
